Cytokinetics
CYTK
#1898
Rank
NZ$18.93 B
Marketcap
NZ$139.45
Share price
-1.44%
Change (1 day)
125.72%
Change (1 year)

Earnings for Cytokinetics (CYTK)

Earnings in 2026 (TTM): -NZ$1.43 Billion

According to Cytokinetics 's latest financial reports the company's current earnings are NZ$0.10 Billion. In 2025 the company made an earning of -NZ$1.36 Billion a decrease over its 2024 earnings that were of -NZ$1.02 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytokinetics from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$1.43 Billion4.95%
2025 -NZ$1.36 Billion33.15%
2024 -NZ$1.02 Billion12.03%
2023 -NZ$0.91 Billion35.3%
2022 -NZ$0.68 Billion80.65%
2021 -NZ$0.38 Billion69.15%
2020 -NZ$0.22 Billion4.6%
2019 -NZ$0.22 Billion14.49%
2018 -NZ$0.19 Billion-16.83%
2017 -NZ$0.23 Billion-812.8%
2016 NZ$30.96 M-147.81%
2015 -NZ$64.77 Million156.05%
2014 -NZ$25.3 Million-56.56%
2013 -NZ$58.24 Million-16.48%
2012 -NZ$69.73 Million-15.65%
2011 -NZ$82.67 Million-3.24%
2010 -NZ$85.43 Million-308.68%
2009 NZ$40.93 M-141.87%
2008 -NZ$97.77 Million0.21%
2007 -NZ$97.56 Million-7.91%
2006 -NZ$0.11 Billion37.42%
2005 -NZ$77.09 Million16.13%
2004 -NZ$66.38 Million-19.29%
2003 -NZ$82.25 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
NZ$15.69 B-1,195.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
-NZ$53.64 Million-96.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$0.32 B-122.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-NZ$0.47 Billion-67.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
-NZ$40.61 Million-97.17%๐Ÿ‡บ๐Ÿ‡ธ USA